Digital Repository

Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers

Show simple item record

dc.contributor.author BHATTACHARJEE, ANINDYA S. en_US
dc.contributor.author Joshi, Samir V. en_US
dc.contributor.author Naik, Shilpa en_US
dc.contributor.author Sangle, Shashikala en_US
dc.contributor.author ABRAHAM, NIXON M. en_US
dc.date.accessioned 2020-12-01T04:04:05Z
dc.date.available 2020-12-01T04:04:05Z
dc.date.issued 2020-11 en_US
dc.identifier.citation EClinicalMedicine, 28. en_US
dc.identifier.issn 2589-5370 en_US
dc.identifier.uri http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/5388
dc.identifier.uri https://doi.org/10.1016/j.eclinm.2020.100575 en_US
dc.description.abstract Background:COVID-19 threatens the global community because a large fraction of infected people areasymptomatic, yet can effectively transmit SARS-CoV-2. Finding and isolating these silent carriers is a crucialstep in confining the spread of the disease. A sudden loss of the sense of smell has been self-reported byCOVID-19 patients across different countries, consistent with expression of the molecular factors mediatingSARS-CoV-2 uptake into human olfactory epithelial supporting cells. However, precise quantification of olfac-tory loss in asymptomatic COVID-19 carriers is missing to date. Methods: To quantify olfactory functions in asymptomatic COVID-19 patients, we designed an olfactory-action meter that determines detectability indices at different odor concentrations and an olfactory matching accuracy score using monomolecular odors. The optimization of test parameters allowed us to reliably and accurately assess olfactory deficits in a patient within 20 minutes. Findings: Measurement of detection indices at low concentrations revealed a 50% reduction in asymptomaticCOVID-19 carriers. Further, patients with better detection scores showed significantly reduced olfactory matching accuracies compared to normal healthy subjects. Our quantification of olfactory loss, considering all parameters, identified 82% of the asymptomatic SARS-CoV-2 carriers with olfactory deficits. However, subjective evaluation, only 15% of the patients noticed a compromised ability to smell. Interpretation: Compromised olfactory fitness can serve as a strong basis for identifying asymptomaticCOVID-19 patients. Detailed design specifications and protocols provided here should enable the develop-ment of a sensitive, fast, and economical screening strategy that can be administered to large populations to prevent the rapid spread of COVID-19. Funding:This work was supported by the DBT Wellcome Trust India Alliance intermediate grant (IA/I/14/1/501,306 to N.A.) and UGC NET Fellowship (A.B.). All the funding sources played no roles in the study.© 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license en_US
dc.language.iso en en_US
dc.publisher Elsevier B.V. en_US
dc.subject COVID-19| Silent carriers en_US
dc.subject SARS-CoV-2 en_US
dc.subject Olfactory loss en_US
dc.subject Loss of the sense en_US
dc.subject 2020 en_US
dc.subject 2020-NOV-WEEK4 en_US
dc.subject TOC-NOV-2020 en_US
dc.title Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers en_US
dc.type Article en_US
dc.contributor.department Dept. of Biology en_US
dc.identifier.sourcetitle EClinicalMedicine en_US
dc.publication.originofpublisher Foreign en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search Repository


Advanced Search

Browse

My Account